PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Woodlands Health Campus, Singapore, Singapore. jaimelin06@gmail.com.\', \'Department of General Medicine, Warrington and Halton Hospitals NHS Trust, Warrington, UK.\', \'Department of Medicine, Woodlands Health Campus, Singapore, Singapore.\', \'Department of Acute Medicine, Queens Hospital, Romford, England, UK.\', \'Division of Infectious Diseases, Mayo Clinic College of Medicine, Rochester, USA.\', \'Department of Infectious Disease, Western Health, Footscray, Australia.\', \'Department of Infectious Diseases, Singapore General Hospital, Singapore, Singapore.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s15010-020-01557-7
?:doi
?:hasPublicationType
?:journal
  • Infection
is ?:pmid of
?:pmid
?:pmid
  • 33389708
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.171
?:rankingScore_hIndex
  • 64
is ?:relation_isRelatedTo_publication of
?:title
  • Remdesivir in Coronavirus Disease 2019 (COVID-19) treatment: a review of evidence.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all